Neuroinflammation plays a central role in the pathogenesis and progression of Parkinson’s disease (PD). Astrocytes emerged as key modulators of the inflammatory response in the brain, undergoing molecular, morphological, and functional remodelling in response to the pro-inflammatory environment associated with PD pathology. Reactive astrocytes encompass a heterogeneous range of molecular and functional states that are shaped by the specific pathophysiological context. Reciprocal interactions between reactive astrocytes and microglia may establish a self-reinforcing inflammatory loop, which may potentially worsen dopaminergic neuron damage and thereby contribute to PD progression. Furthermore, astrocytes perform several homeostatic functions that contribute to neuronal survival, including neurotransmitter uptake and recycling, and production of neurotrophic factors (NTFs). In PD, these physiological functions may be impaired or dysregulated, further compromising neuronal integrity and increasing neuronal vulnerability to degeneration. Thus, modulation of astrocyte reactivity and function may represent a promising therapeutic strategy for PD. Targeting specific molecules and signalling pathways involved in astrocytic homeostasis, neuroinflammatory responses and interaction with other Central Nervous System (CNS)-resident cells may help restore their protective functions while limiting detrimental inflammatory processes. Primary mouse astrocyte cultures represent a useful experimental model for investigating the molecular mechanisms underlying astrocyte reactivity in the context of PD.
Neuroinflammation plays a central role in the pathogenesis and progression of Parkinson’s disease (PD). Astrocytes emerged as key modulators of the inflammatory response in the brain, undergoing molecular, morphological, and functional remodelling in response to the pro-inflammatory environment associated with PD pathology. Reactive astrocytes encompass a heterogeneous range of molecular and functional states that are shaped by the specific pathophysiological context. Reciprocal interactions between reactive astrocytes and microglia may establish a self-reinforcing inflammatory loop, which may potentially worsen dopaminergic neuron damage and thereby contribute to PD progression. Furthermore, astrocytes perform several homeostatic functions that contribute to neuronal survival, including neurotransmitter uptake and recycling, and production of neurotrophic factors (NTFs). In PD, these physiological functions may be impaired or dysregulated, further compromising neuronal integrity and increasing neuronal vulnerability to degeneration. Thus, modulation of astrocyte reactivity and function may represent a promising therapeutic strategy for PD. Targeting specific molecules and signalling pathways involved in astrocytic homeostasis, neuroinflammatory responses and interaction with other Central Nervous System (CNS)-resident cells may help restore their protective functions while limiting detrimental inflammatory processes. Primary mouse astrocyte cultures represent a useful experimental model for investigating the molecular mechanisms underlying astrocyte reactivity in the context of PD.
Neuroinflammation in astrocytes: implications for Parkinson's disease
ZAGO, ALESSANDRA
2025/2026
Abstract
Neuroinflammation plays a central role in the pathogenesis and progression of Parkinson’s disease (PD). Astrocytes emerged as key modulators of the inflammatory response in the brain, undergoing molecular, morphological, and functional remodelling in response to the pro-inflammatory environment associated with PD pathology. Reactive astrocytes encompass a heterogeneous range of molecular and functional states that are shaped by the specific pathophysiological context. Reciprocal interactions between reactive astrocytes and microglia may establish a self-reinforcing inflammatory loop, which may potentially worsen dopaminergic neuron damage and thereby contribute to PD progression. Furthermore, astrocytes perform several homeostatic functions that contribute to neuronal survival, including neurotransmitter uptake and recycling, and production of neurotrophic factors (NTFs). In PD, these physiological functions may be impaired or dysregulated, further compromising neuronal integrity and increasing neuronal vulnerability to degeneration. Thus, modulation of astrocyte reactivity and function may represent a promising therapeutic strategy for PD. Targeting specific molecules and signalling pathways involved in astrocytic homeostasis, neuroinflammatory responses and interaction with other Central Nervous System (CNS)-resident cells may help restore their protective functions while limiting detrimental inflammatory processes. Primary mouse astrocyte cultures represent a useful experimental model for investigating the molecular mechanisms underlying astrocyte reactivity in the context of PD.| File | Dimensione | Formato | |
|---|---|---|---|
|
Zago_Alessandra.pdf
accesso aperto
Dimensione
572.82 kB
Formato
Adobe PDF
|
572.82 kB | Adobe PDF | Visualizza/Apri |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/114904